Literature DB >> 9990333

Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders.

F Brignole1, M De Saint-Jean, M Goldschild, F Becquet, A Goguel, C Baudouin.   

Abstract

Fas antigen (CD95) is a membrane receptor that plays a major role in induction of apoptosis. In surface conjunctival epithelial cells the expressions of Fas, Fas ligand, the apoptotic marker APO2.7 and of HLA DR class II antigen, a membrane marker known to be expressed in inflammatory conditions were investigated. Impression cytology specimens were collected in 65 patients: 20 normal ones, 15 contact lens wearers, 20 receiving chronic topical antiglaucoma treatment and 10 with nonspecific chronic conjunctivitis. Cells were processed for flow cytometry, using monoclonal antibodies to Fas, Fas ligand, APO2.7, HLA DR antigens and a negative isotypic control. Percentages of positive cells were recorded and levels of fluorescence quantified using fluorescent beads at standardized fluorescence intensities. In addition, a human conjunctival cell line was incubated with anti-Fas stimulating antibodies in order to test Fas-induced apoptosis in vitro. Fas was found in all specimens in most of the conjunctival cells, but quantitation of levels of fluorescence showed a significantly higher expression in pathologic eyes than in normal ones. Fas ligand and APO2.7 were variably expressed by conjunctival cells, but in a significantly higher percentage of cells in pathological eyes than in normal ones. In these eyes a strong expression of HLA DR was also observed, whereas normal eyes showed lowest levels. Highly significant correlations were found between Fas, Fas ligand, APO2.7 and HLA DR levels. Anti-Fas antibodies in vitro induced strong apoptosis in epithelial cells as confirmed by APO2.7 expression and DAPI staining. This study confirms that conjunctival epithelial cells normally express Fas antigen, and more inconstantly its ligand, as do corneal ones or keratinocytes. Fluorescence quantitation by flow cytometry showed much higher expression in inflammatory eyes than in normal ones, and demonstrated a strong correlation between apoptotic and inflammatory pathways in the ocular surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9990333     DOI: 10.1006/exer.1998.0566

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  17 in total

1.  A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva.

Authors:  Tanima Bose; Aihua Hou; Ryan Lee; Louis Tong; K George Chandy
Journal:  J Vis Exp       Date:  2017-07-05       Impact factor: 1.355

2.  Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.

Authors:  Françoise Brignole; Pierre-Jean Pisella; Bénédicte Dupas; Vincent Baeyens; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

3.  The use of impression cytology in the follow-up of severe ocular burns.

Authors:  Jean-Jacques Gicquel; Renaud Navarre; Maria Elena Langman; Alix Coulon; Stephanie Balayre; Serge Milin; Martial Mercie; Alexis Rossignol; Anne Barra; Pierre-Marie Levillain; Jean-Marc Gombert; Paul Dighiero
Journal:  Br J Ophthalmol       Date:  2007-04-30       Impact factor: 4.638

4.  Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

Authors:  P J Pisella; P Pouliquen; C Baudouin
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

5.  Soluble Fas and Fas ligand in human tear fluid after photorefractive keratectomy.

Authors:  I Tuominen; M Vesaluoma; A M Teppo; C Grönhagen-Riska; T Tervo
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

6.  Corneal epithelial cell biocompatibility to silicone hydrogel and conventional hydrogel contact lens packaging solutions.

Authors:  M B Gorbet; N C Tanti; L Jones; H Sheardown
Journal:  Mol Vis       Date:  2010-02-19       Impact factor: 2.367

7.  Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.

Authors:  Dorota Pozarowska
Journal:  Clin Ophthalmol       Date:  2010-10-21

8.  In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells.

Authors:  Pascale Hamard; Catherine Blondin; Caroline Debbasch; Jean-Michel Warnet; Christophe Baudouin; Françoise Brignole
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-07       Impact factor: 3.117

9.  HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease.

Authors:  Seth P Epstein; Neha Gadaria-Rathod; Yi Wei; Maureen G Maguire; Penny A Asbell
Journal:  Exp Eye Res       Date:  2013-04-06       Impact factor: 3.467

10.  Characterization and short-term culture of cells recovered from human conjunctival epithelium by minimally invasive means.

Authors:  Hernán Martínez-Osorio; Margarita Calonge; Alfredo Corell; Roberto Reinoso; Antonio López; Itziar Fernández; Eloína Gutiérrez San José; Yolanda Diebold
Journal:  Mol Vis       Date:  2009-10-27       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.